VIII.3. Optimization of Protection for Medical Exposures in Nuclear Medicine 2. Dose to patient Postgraduate Educational Course in Radiation Protection.

Slides:



Advertisements
Similar presentations
Diagnostic tests include: Physical examination Laboratory tests Imaging Endoscopic examination Biopsy Surgery Molecular testing How is cancer diagnosed?
Advertisements

CT Organ Dose - Part 1 Estimating organ dose for patients Michael F. McNitt-Gray, Ph.D., DABR David Geffen School of Medicine at UCLA.
EPA Radiogenic Cancer Risk Projections for the U.S. Population Michael Boyd Radiation Protection Division U.S. Environmental Protection Agency 2011 OAS.
Physics of Radiography X-ray tube and circuitry What we know so far… A photon is…………? A negatively charged electron is attracted to what kind of charge.
5 th September 2005 Paul Collins Computed Tomography Dosimetry Assessment of Effective Dose in Computed Tomography using an Anthropomorphic Phantom Paul.
Alexander Brandl ERHS 630 Radiation and Tissue Weighting Factors Environmental and Radiological Health Sciences.
Nuclear Medicine Spring 2009 FINAL. 2 NM Team Nuclear medicine MD Nuclear medicine MD Physicist Physicist Pharmacist Pharmacist Technologist Technologist.
MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature 5/15/2009.
Radioactive Drug Research Committee
Quantities and Measurements - 2 Dosimetric Quantities
IAEA Quantities and Measurements - 3 Radiation Protection Quantities Day 3 – Lecture 1 1.
Radiation Dosimetry Dose Calculations D, LET & H can frequently be obtained reliably by calculations: Alpha & low – Energy Beta Emitters Distributed in.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
P4: Radiation for Life Lesson 13: Treatment (part 1)
Radiology is concerned with the application of radiation to the human body for diagnostically and therapeutically purposes. This requires an understanding.
Radioisotopes in Medicine
Photon and Energy Fluence
Chemistry and Imaging. Body Chemistry In order to be an effective health care professional, an individual must have an understanding of basic chemistry.
Nuclear Medicine By: George Bastawros What is nuclear medicine? According to Merriam-Webster dictionary nuclear medicine is a branch of medicine dealing.
Nuclear Medicine By: Amanda Taulanga 3B.
Introduction to Nuclear Medicine
Medical Imaging Technology
 Cells – smallest unit of life  Tissue – a collection of cells that work for a common function.
Radioactivity and Nuclear Energy Sections 19.5 – 19.6 By: Group 3.
National Committee for the Certification of Radiation Protection Officer BIOLOGICAL EFFECTS OF IONIZING RADIATION.
Medical Technology. Medical imaging Medical imaging is used to produce images of organs and tissues within the body for use in diagnosis and treatment.
Fundamentals of Radiation
Radiophamaceuticals in Nuclear Cardiac Imaging Vasken Dilsizian, M.D. Professor of Medicine and Radiology Director of Cardiovascular Nuclear Medicine and.
1 Nuclear and non-nuclear safety aspects Philippe ANTOINE SCKCEN Name, company and chapter.
Workshop for radioactivity and experimental observations 1.
RT-PCR:PRKWNK1, WNK1, T39 T40 (232 bp) Bedingungen: 2% TBE 90 V 1h 40 min 9 µl PCR-Probe 2 µl Ladepuffer _Gewebe_1_A1_T39T40_calb M
Internal Radiation Dosimetry Lab 9. Radiation Measurement We use different terms depending on whether: 1.The radiation is coming from a radioactive source.
Need for Internal Dosimetry: Fundamentals to Clinical Practice – and Opportunity to Personalize Cancer Therapy Darrell R. Fisher Pacific Northwest National.
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
RT-PCR: PRKWNK1,WNK1, T39 T40 (232 bp), Reamplifikation _Reampli_Gewebe_1_A1_T39T40_calb Bedingungen: 2% TBE 90V 1h 40min 9 µ Reampli-Probe 2 µl.
RT-PCR: PC326, T146 T147 (240 bp) _Gewebe_1_B1_T146T147_calb Bedingungen: 2% TBE 90V 1h 40min 9 µl PCR-Probe 2 µl LB M
10 CFR 835 Amendment Peter V. O’Connell, CHP U.S. Department of Energy Accelerator Safety Workshop August 8, 2007 Argonne National Laboratory.
Health Physics 1b: Dosimetric Quantities (and terms)
Part 2.
Understanding radiation units L02
Radiation Safety and You Brian Kessler Zettl Group Safety Talk September 7, 2006.
Use of Effective Dose as an RDRC Study Limit
Section 1Nuclear Changes Section 1: What is Radioactivity?
Evaluation of absorbed fractions for beta- gamma radionuclides in ellipsoidal volumes of soft tissue through Geant4 Ernesto Amato 1, Domenico Lizio 2 and.
Medical Imaging Technologies Medical imaging produces images of organs and tissues within the body for use in diagnosis and treatment.
3/2003 Rev 1 II.1.2 – slide 1 of 32 IAEA Post Graduate Educational Course Radiation Protection and Safe Use of Radiation Sources Session II.1.2 Part IIQuantities.
Implementation Program of Two-dosimeter Algorithm for Better Estimation of Effective Dose during Maintenance Periods at KNPPs Hee Geun Kim.
RT-PCR: BCLG, T84 T85 (487bp) _Gewebe_1_A2_T84T85_calb Bedingungen: 2% TBE 90V 1h 45min 9 µl PCR-Produkt 2 µl LB M
DR.(LT.COL.)D.ACHARYA M.B.B.S.(KOLKATTA) M.S.(DELHI) P.G.D.H.H.M.(PUNE)
Human Body Systems.
Nuclear Chemistry: The Heart of Matter. 2 Radioisotopes Radioactive decay Radioactive decay – Many isotopes are unstable – Many isotopes are unstable.
TDM Therapeutic Drug Monitoring
VIII.3. Optimization of Protection for Medical Exposures in Nuclear Medicine. 4. Guidance levels Postgraduate Educational Course in Radiation Protection.
06/02/2016radiation safety - level 51 Radiation safety level 5 Frits Pleiter.
Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.
NUCLEAR MEDICINE.  High Energy Photon  Ionizing Radiation --Radiopharmaceutical  Exposes Detector  Projection Data  Dynamic / Physiologic Here we.
Nuclear Medicine Technique I 355 RAD L.Aya Ahmed Saeed.
Introduction to nuclear medicine NMT 231 L.Aya Ahmed Saeed.
Introduction to NM Omima Adam NMT 231. What is nuclear medicine NM Is the branch of medicine that uses radiation and nuclear properties of radionuclide's.
Interaction of x-ray photons (and gamma ray photons) with matter.
Nuclear medicine Essential idea Nuclear radiation, whilst dangerous owing to its ability to damage cells and cause mutations, can also be used to both.
 Two reasons medical tracers can be placed in a body:  Diagnose disease or Treat Disease  In both cases, several factors must be accounted for:  Gamma.
4/4/16 Starter: Practice: Body Systems Notes Human Body Systems notes 4/4/16 Application/Connection: Whats the Function WS? Exit: How similar are.
IONIZING RADIATION IN MEDICINE.
David Sutton or Colin Martin But Borrowed from Jerry Williams
Radiation Dose to Patients from Radiopharmaceuticals
Principles of Radiation Protection
Radioisotopes in Medicine
Estimation of the effects of a lead vest on dose reduction for NPP workers using Monte Carlo calculations KIM JEONG-IN.
Presentation transcript:

VIII.3. Optimization of Protection for Medical Exposures in Nuclear Medicine 2. Dose to patient Postgraduate Educational Course in Radiation Protection and the Safety of Radiation Sources

VIII.3.2. Dose to patient2 CLINICAL DOSIMETRY (BSS) II.20. Registrants and licensees shall ensure that the following items be determined and documented: (d) In diagnosis or treatment with unsealed sources, representative absorbed doses to patients;

VIII.3.2. Dose to patient3 Conception of absorbed dose in NM The calculation of the absorbed dose - a tricky problem, because of several factors: n 1. the distribution of the radionuclide within the body and its uptake in certain critical organs n 2. inhomogeneous distribution of the nuclide even within the critical organ n 3. the biological half-life of the nuclide, which may vary with patients' ages and may be modified by disease or pathological conditions.

VIII.3.2. Dose to patient4 Treatment of Hepatocellular Carcinoma with 131 I-Lipiodol CT scan demonstrating non-homogeneous distribution of Lipiodol. Tumour can not be treated as a homogenous sphere.

VIII.3.2. Dose to patient5 Absorbed dose to an organ is determined by: Radionuclide Activity administered Activity in the organ Size and shape of the organ Activity in other organs Kinetics of radiopharmaceutical Quality of radiopharmaceutical

VIII.3.2. Dose to patient6 The MIRD System of Internal Absorbed Dose Calculation l MIRD - Medical Internal Radiation Dosimetry developed by the Society of Nuclear Medicine l The organ containing the radionuclide is called the source organ l We wish to calculate the absorbed dose to the target organ l The source and target organs may be the same l The amount of radiation from the source reaching the target must be known

VIII.3.2. Dose to patient7 Absorbed Dose in the Target Organ The absorbed dose will be equal to the total amount of energy that is emitted by the source organ X the fraction of that energy that is absorbed in the target organ divided by the mass of the target organ

VIII.3.2. Dose to patient8 Determination of the Absorbed Fraction The only method available is CALCULATION CALCULATION using Monte Carlo modelling

VIII.3.2. Dose to patient9 What is Monte Carlo Modelling? l Essentially a ray tracing method, in which the fates of individual particles are determined l The method is based on randomly sampling a probability distribution for each successive interaction l Typically, the history of 10 million photons will be modeled l Requires detailed knowledge of the absorption and scattering coefficients for the specific energies and for the various types of tissues.

VIII.3.2. Dose to patient10 General MIRD Equation D = ÃS(S = nE  /m) D = ÃS(S = nE  /m) Ã is the cumulated activity, nE is the emitted energy per disintegration,  is the absorbed fraction and m the mass of the organ. S is dependent on the radionuclide and the geometry. S-values for different radionuclides and source/target organs can be found in MIRD publications

VIII.3.2. Dose to patient11 ICRP ICRP publications 53, 62 & 80 give the absorbed dose per unit activity administered (mGy/MBq) for different radiopharmaceuticals and different organs as well as the effective dose.

VIII.3.2. Dose to patient12 Biokinetic models Extra- cellular Plasma Kidneys Bladder Injection Calculate time-activity curves for the different compartments and calculate the cumulated activity.

Effective dose Tissue or organWeighting factor Gonads0.20 Bone marrow (red)0.12 Colon0.12 Lung0.12 Stomach0.12 Bladder0.05 Breast0.05 Liver0.05 Oesophagus0.05 Thyroid0.01 Bone surface0.01 Remainder (adrenals, kidney, muscle,0.05 upper large intestine, small intestine, pancreas, spleen, thymus, uterus, brain)

Effective dose - bone scan Effective dose - bone scan Organ/tissuew T mGy/MBq Produkt Gonads Bone marrow Colon Lungs Stomach Bladder Breast Liver Esophagus Thyroid Skin Bone surface Remainder Effective dose (mSv/MBq):0.0039

Effective dose (mSv) cardioangiography thyroidI-131 CT pelvismyocardTl-201 large intestine CT abdomenCBFTc-99m urographythyroidI-123 lumbar spineboneTc-99m thyroidTc-99m liverTc-99m lungTc-99m chestrenographyI-131 extremities blood volumeI-125 dentalclearanceCr-51 X-ray Nuclear medicine